Prepayment Scheme for HRT Prescriptions in England Delayed Until 2023

Peter Russell

March 23, 2022

A Government announcement that a prepayment scheme enabling women in England to pay a single annual prescription charge for hormone replacement therapy (HRT) will not be implemented until next year has been described as "disappointing". Prescriptions are currently free in Scotland and Wales.

The Royal Pharmaceutical Society (RPS) warned that it would add to inequalities for women across the country.

The Department of Health and Social Care announced last October that it would cut the cost of repeatable HRT prescriptions, with a potential saving of up to £205 a year as a result. The move could mean that women would only have to pay one charge of £18.70 for up to a 12-month supply of HRT.

Minister for women's health, Maria Caulfield, told MPs in October: "For a woman currently prescribed HRT on a 3-monthly interval, moving to a 12-monthly repeatable prescription will make a saving of £56.10 a year."

Ministers pledged to work with NHS England to implement longer prescribing cycles, in line with guidelines set by the National Institute for Health and Care Excellence. They also promised to examine combining both oestrogen and progesterone into one prescription, further helping around 10% of women on HRT.

Consultation on the Scheme's Practicalities

However, last week Ms Caulfield told the Commons Women and Equalities Committee, which is holding an inquiry into menopause and the workplace, that the scheme was not likely to be in place until April next year.

She told the Committee that "we are looking at the scheme right now to issue what's called a prepayment certificate, specifically for HRT, so this is different to prepayment certificates for other medication that are in existence now".

She explained: "We have to do consultation with the various bodies, so the pharmacy bodies, with the Royal colleges as well, around the practicalities of rolling this out."

Her evidence prompted Carolyn Harris MP (Lab, Swansea East) to write to the minister asking for an explanation for the delay, saying she had been "led to believe by the Department that implementation would happen in a matter of months".

'Frustrating' Delay

Prescriptions for HRT have more than doubled in England over the past 5 years, from 238,007 in January 2017 to 537,986 in December 2021.

Responding to the latest situation, Thorrun Govind, Chair of the RPS in England, said: "This is disappointing news. Delaying this move will frustrate many who already pay for monthly HRT prescriptions and will further drive health inequalities already experienced by women across the country.

"Women experiencing the menopause need support to stay well and remain in the workplace. For some, HRT prescriptions are an essential part of this but also a financial drain during a cost of living crisis.

"We believe everyone should have access to the medicines they need, regardless of ability to pay, and will continue to call on the Government to scrap prescription charges in England altogether."


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.